Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
Vera Levina, Adele M. Marrangoni, Richard DeMarco et al. · 2008
Read Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties by Vera Levina, Adele M. Marrangoni, Richard DeMarco et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003077.txt.
Description
Vera Levina, Adele Marrangoni, Richard DeMarco and co-authors enriched lung cancer stem cells with drug selection in 2008. Cancer stem cells are thought to regrow tumors after chemotherapy, though direct confirmation was still forthcoming. The team asked whether drug treatment could enrich and maintain such cells.
They then examined the enriched cells' cytokine network plus tumor-forming and metastatic properties. Published in PLOS ONE, drug-selected cells model the survivors that relapse is made of. Studying them is a step toward treatments aimed at the cells chemotherapy leaves behind. Full methods, data, and references appear in the complete article for readers who want more detail.
Catalog record
| CREATOR | Vera Levina, Adele M. Marrangoni, Richard DeMarco et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 73 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003077